202 related articles for article (PubMed ID: 35409155)
1. Rare Subtype of Endometrial Cancer: Undifferentiated/Dedifferentiated Endometrial Carcinoma, from Genetic Aspects to Clinical Practice.
Tung HJ; Wu RC; Lin CY; Lai CH
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409155
[TBL] [Abstract][Full Text] [Related]
2. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
Kobayashi Y; Kitazono I; Akahane T; Yanazume S; Kamio M; Togami S; Nohara S; Sakamoto I; Yokoyama S; Tabata K; Kobayashi H; Tanimoto A
Pathol Oncol Res; 2021; 27():1610013. PubMed ID: 35002543
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
4. PPP2R1A mutations are common in the serous type of endometrial cancer.
Nagendra DC; Burke J; Maxwell GL; Risinger JI
Mol Carcinog; 2012 Oct; 51(10):826-31. PubMed ID: 21882256
[TBL] [Abstract][Full Text] [Related]
5. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
[TBL] [Abstract][Full Text] [Related]
6. SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.
Kolin DL; Quick CM; Dong F; Fletcher CDM; Stewart CJR; Soma A; Hornick JL; Nucci MR; Howitt BE
Am J Surg Pathol; 2020 Feb; 44(2):263-270. PubMed ID: 31567195
[TBL] [Abstract][Full Text] [Related]
7. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
8. Histomolecular features of high-grade endometrial cancers.
Morotti M; Soleymani Majd H; Casarin J; Alazzam M; Damato S
Minerva Med; 2021 Feb; 112(1):20-30. PubMed ID: 33104303
[TBL] [Abstract][Full Text] [Related]
9. Use of mutation profiles to refine the classification of endometrial carcinomas.
McConechy MK; Ding J; Cheang MC; Wiegand K; Senz J; Tone A; Yang W; Prentice L; Tse K; Zeng T; McDonald H; Schmidt AP; Mutch DG; McAlpine JN; Hirst M; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG
J Pathol; 2012 Sep; 228(1):20-30. PubMed ID: 22653804
[TBL] [Abstract][Full Text] [Related]
10. Molecular Genetics of Endometrial Carcinoma.
Bell DW; Ellenson LH
Annu Rev Pathol; 2019 Jan; 14():339-367. PubMed ID: 30332563
[TBL] [Abstract][Full Text] [Related]
11. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
van Niekerk CC; van Dijck JAAM; Verbeek ALM
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
[TBL] [Abstract][Full Text] [Related]
12. Undifferentiated-dedifferentiated endometrial carcinoma; the reappearance of an old friend with insights into the new data.
Mourtzoukou D; Thomakos N; Lazaris AC; Vlachodimitropoulos D; Goutas N; Sotiropoulou M; Rodolakis A; Nonni A
APMIS; 2023 Jun; 131(6):229-236. PubMed ID: 36965090
[TBL] [Abstract][Full Text] [Related]
13. Beyond Serous: Treatment Options for Rare Endometrial Cancers.
Crane E
Curr Treat Options Oncol; 2022 Nov; 23(11):1590-1600. PubMed ID: 36205807
[TBL] [Abstract][Full Text] [Related]
14. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
[TBL] [Abstract][Full Text] [Related]
15. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract][Full Text] [Related]
16. Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Hoang LN; Kinloch MA; Leo JM; Grondin K; Lee CH; Ewanowich C; Köbel M; Cheng A; Talhouk A; McConechy M; Huntsman DG; McAlpine JN; Soslow RA; Gilks CB
Am J Surg Pathol; 2017 Feb; 41(2):245-252. PubMed ID: 28079598
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
Helpman L; Perri T; Lavee N; Hag-Yahia N; Chariski HA; Kalfon S; Derazne E; Beiner ME; Kadan Y; Fishman A; Korach J; Covens A; Gien L
Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
[TBL] [Abstract][Full Text] [Related]
18. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
19. [Molecular pathology of endometrial carcinoma - a review].
Kajo K; Vallová M; Biró C; Bognár G; Macháleková K; Závodná K; Galbavý Š; Žúbor P
Cesk Patol; 2015; 51(2):65-73. PubMed ID: 25970717
[TBL] [Abstract][Full Text] [Related]
20. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]